Advances in metformin-based metabolic therapy for non-small cell lung cancer

Therapeutic approaches that target the metabolism of tumor cells have been a popular research topic in recent years. Previous studies have demonstrated that glycolysis inhibitors reduce the proliferation of non-small cell lung cancer (NSCLC) cells by interfering with the aerobic glycolytic pathway....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Na, Zhou, Yi-Shu, Wang, Li-Cui, Huang, Jin-Bai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808708/
https://www.ncbi.nlm.nih.gov/pubmed/35039878
http://dx.doi.org/10.3892/or.2022.8266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808708/
https://www.ncbi.nlm.nih.gov/pubmed/35039878
http://dx.doi.org/10.3892/or.2022.8266

Ejemplares similares